15 Participants Needed

Human-AI Collaboration for Decision Making

JM
Overseen ByJeremy M Wolfe, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Brigham and Women's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The study is one part of a "bundle" of experiments that constitute Project Three of a National Eye Institute grant. Project Three includes a series of experiments that investigate how changing the input from a simulated AI can affect the decisions made by human observers in a two-alternative forced choice task (like the decision to recall a woman for further examination in mammography). HAICT 7, the experiment described here, investigates how changing prevalence affects human performance when AI is used as a Second Reader.

Who Is on the Research Team?

JM

Jeremy M Wolfe, PhD

Principal Investigator

Brigham and Women's Hospital

Are You a Good Fit for This Trial?

This trial is open to everyone who can enroll online. However, participants must pass the Ishihara color vision test and have at least 20/25 vision with correction if needed.

Inclusion Criteria

- All welcome to enroll on line

Exclusion Criteria

My vision is at least 20/25 with glasses or contacts.
Must pass the Ishihara color vision screening test

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Data Collection

Participants complete 8 blocks of tasks with varying AI input and prevalence rates

Up to one week
Multiple sessions

Follow-up

Participants are monitored for performance and subjective feedback after task completion

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Simulated Second Reader AI
  • Target Prevalence
Trial Overview The study tests how simulated AI as a Second Reader affects human decision-making in tasks like mammography screening when the frequency of cases (prevalence) changes.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: ExperimentExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security